Alexandre Chlenski

2.3k total citations
44 papers, 1.8k citations indexed

About

Alexandre Chlenski is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Alexandre Chlenski has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 28 papers in Neurology and 23 papers in Cancer Research. Recurrent topics in Alexandre Chlenski's work include Neuroblastoma Research and Treatments (28 papers), Cancer, Hypoxia, and Metabolism (20 papers) and Epigenetics and DNA Methylation (11 papers). Alexandre Chlenski is often cited by papers focused on Neuroblastoma Research and Treatments (28 papers), Cancer, Hypoxia, and Metabolism (20 papers) and Epigenetics and DNA Methylation (11 papers). Alexandre Chlenski collaborates with scholars based in United States, Canada and France. Alexandre Chlenski's co-authors include Susan L. Cohn, Helen R. Salwen, Qiwei Yang, Yufeng Tian, Shuqing Liu, Ryoichi Oyasu, Kathleen V. Ketels, Lisa J. Guerrero, Г. И. Коровайцева and Koh‐ichi Nakashiro and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Alexandre Chlenski

44 papers receiving 1.8k citations

Peers

Alexandre Chlenski
Meena Gujrati United States
Arend Koch Germany
Chio Oka Japan
Yuan Zhu Germany
Marc Valentine United States
Lauri Miller United States
Lu Q. Le United States
J. M. Bruner United States
Meena Gujrati United States
Alexandre Chlenski
Citations per year, relative to Alexandre Chlenski Alexandre Chlenski (= 1×) peers Meena Gujrati

Countries citing papers authored by Alexandre Chlenski

Since Specialization
Citations

This map shows the geographic impact of Alexandre Chlenski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Chlenski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Chlenski more than expected).

Fields of papers citing papers by Alexandre Chlenski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Chlenski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Chlenski. The network helps show where Alexandre Chlenski may publish in the future.

Co-authorship network of co-authors of Alexandre Chlenski

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Chlenski. A scholar is included among the top collaborators of Alexandre Chlenski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Chlenski. Alexandre Chlenski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chlenski, Alexandre, Tong Wu, Sang Mee Lee, et al.. (2024). Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures. Cancer Research Communications. 4(8). 2255–2266. 2 indexed citations
2.
Chennakesavalu, Mohansrinivas, Ruitu Lyu, Alexandre Chlenski, et al.. (2024). 5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma. JCO Precision Oncology. 8(8). e2300297–e2300297. 7 indexed citations
3.
Chennakesavalu, Mohansrinivas, et al.. (2023). Adrenergic and mesenchymal signatures are identifiable in cell‐free DNA and correlate with metastatic disease burden in children with neuroblastoma. Pediatric Blood & Cancer. 71(1). e30735–e30735. 6 indexed citations
4.
Chlenski, Alexandre, Chanyoung Park, Helen R. Salwen, et al.. (2019). Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma. Molecular Cancer Therapeutics. 18(3). 507–516. 20 indexed citations
5.
Applebaum, Mark A., Jason Karpus, Diana C. West-Szymanski, et al.. (2019). 5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma. Clinical Cancer Research. 26(6). 1309–1317. 23 indexed citations
6.
Oshima, Go, Michael J. Bolt, Alexandre Chlenski, et al.. (2018). DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs. Cancer Research. 79(3). 650–662. 39 indexed citations
7.
Lu, Ziyan, Yufeng Tian, Helen R. Salwen, et al.. (2013). Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells. Anti-Cancer Drugs. 24(5). 484–493. 43 indexed citations
8.
Ostler, Kelly R., Qiwei Yang, Timothy J. Looney, et al.. (2012). Truncated DNMT3B Isoform DNMT3B7 Suppresses Growth, Induces Differentiation, and Alters DNA Methylation in Human Neuroblastoma. Cancer Research. 72(18). 4714–4723. 32 indexed citations
9.
Gu, Song, Yufeng Tian, Alexandre Chlenski, et al.. (2012). Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma. Anti-Cancer Drugs. 23(10). 1054–1066. 43 indexed citations
10.
Peddinti, Radhika, Yufeng Tian, Lisa J. Guerrero, et al.. (2011). Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth. Pediatric Blood & Cancer. 59(4). 642–647. 24 indexed citations
11.
Chlenski, Alexandre & Susan L. Cohn. (2009). Modulation of matrix remodeling by SPARC in neoplastic progression. Seminars in Cell and Developmental Biology. 21(1). 55–65. 119 indexed citations
12.
Zeine, Rana, Helen R. Salwen, Radhika Peddinti, et al.. (2009). Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors. Modern Pathology. 22(7). 950–958. 37 indexed citations
13.
Yang, Qiwei, Yufeng Tian, Shuqing Liu, et al.. (2007). Thrombospondin-1 Peptide ABT-510 Combined with Valproic Acid Is an Effective Antiangiogenesis Strategy in Neuroblastoma. Cancer Research. 67(4). 1716–1724. 70 indexed citations
14.
Liu, Shuqing, Yufeng Tian, Alexandre Chlenski, et al.. (2005). Cross-Talk between Schwann Cells and Neuroblasts Influences the Biology of Neuroblastoma Xenografts. American Journal Of Pathology. 166(3). 891–900. 34 indexed citations
15.
Chlenski, Alexandre, Shuqing Liu, Lisa J. Guerrero, et al.. (2005). SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. International Journal of Cancer. 118(2). 310–316. 93 indexed citations
16.
Chlenski, Alexandre, Shuqing Liu, & Susan L. Cohn. (2003). The regulation of angiogenesis in neuroblastoma. Cancer Letters. 197(1-2). 47–52. 30 indexed citations
17.
Chlenski, Alexandre, Koh‐ichi Nakashiro, Kathleen V. Ketels, Г. И. Коровайцева, & Ryoichi Oyasu. (2001). Androgen receptor expression in androgen‐independent prostate cancer cell lines. The Prostate. 47(1). 66–75. 108 indexed citations
18.
Nakashiro, Koh‐ichi, Yoshiki Hayashi, Tetsuya Tamatani, et al.. (2001). Role of Peroxisome Proliferator-Activated Receptor γ and Its Ligands in Non-Neoplastic and Neoplastic Human Urothelial Cells. American Journal Of Pathology. 159(2). 591–597. 76 indexed citations
19.
Chlenski, Alexandre, Kathleen V. Ketels, Mark S. Talamonti, et al.. (1999). zo-2 gene alternative promoters in normal and neoplastic human pancreatic duct cells. International Journal of Cancer. 83(3). 349–358. 25 indexed citations
20.
Chlenski, Alexandre, Kathleen V. Ketels, Ming‐Sound Tsao, et al.. (1999). Tight junction protein zo-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma. International Journal of Cancer. 82(1). 137–144. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026